EPISODE · Oct 28, 2020 · 31 MIN
GU Podcast (2020): Immune Checkpoint Inhibitors In RCC
from AUAUniversity · host American Urological Association
Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Identify and manage immune related adverse events. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29846
What this episode covers
Immune Checkpoint Inhibitors in RCC At the conclusion of this activity, participants will be able to: 1. Discuss the current immunotherapy options available for the treatment of RCC. 2. Describe both completed and accruing clinical trials that are defining the paradigms of immunotherapy use in RCC. 3. Identify and manage immune related adverse events. This educational series is supported by independent educational grants from: Astellas AstraZeneca Bristol Myers Squibb Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC Merck Pfizer, Inc Sanofi Genzyme UroGen Pharma, Inc. CME Available: https://auau.auanet.org/node/29846
NOW PLAYING
GU Podcast (2020): Immune Checkpoint Inhibitors In RCC
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.